Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02427932 · ClinicalTrials.gov registry record
Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling of Ampicillin and Gentamicin in Peripartum Patients
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 45
- Enrollment target
NCT02427932: Completed study, sponsored by Stanford University.
NCT02427932 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02427932 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
This study proposes to compare the metabolism of Ampicillin and Gentamicin by pregnant women to that of non-pregnant women; the placental transfer over time; and the subsequent metabolism of the transferred drug(s) in the neonate.
Primary Outcome
blood samples will be taken at the above timepoints; data analysis of all specimens will begin approx. 12-15 months from start of study
Interventions
- DRUG Gentamicin
- DRUG Ampicillin
- DRUG Ampicillin and Gentamicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-05 |
| Est. Completion | 2017-01 |
What the finished NCT02427932 record still lists
NCT02427932 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Gentamicin is the first listed.
NCT02427932 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02427932 about?
NCT02427932 is a clinical study titled "Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling of Ampicillin and Gentamicin in Peripartum Patients". This study proposes to compare the metabolism of Ampicillin and Gentamicin by pregnant women to that of non-pregnant women; the placental transfer over time; and the subsequent metabolism of the transferred drug(s) in the neonate.
What is the current status of trial NCT02427932?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2015-05. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02427932?
The interventions under investigation include: Gentamicin (DRUG), Ampicillin (DRUG), Ampicillin and Gentamicin (DRUG).
Who is sponsoring clinical trial NCT02427932?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia